Skip to content

D&A at other companies

Abbott logo
AbbottABT
$658M+56.7%
Medtronic logo
MedtronicMDT
$716M-14.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$30.5M+4.1%
Haemonetics logo
HaemoneticsHAE
$27.32M-3.2%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$84M+12.0%
American Well logo
American WellAMWL
$7.56M-3.0%

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Market cap$1.4B+65.0%
Enterprise value$1.35B
P/S14.7×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: KMTS’s 10-K, filed July 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's D&A?
KMTS (KMTS) reported D&A of $2.33M in Q1 2026.
How has KMTS's D&A changed year-over-year?
KMTS's D&A increased by 26.6% year-over-year, from $1.84M to $2.33M.
What is the long-term trend for KMTS's D&A?
Over 2 years (2024 to 2026), KMTS's D&A has grown at a -13.2% compound annual growth rate (CAGR), from $11.56M to $8.71M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.